Advertisement

Intensive Care Medicine

, Volume 38, Issue 3, pp 445–452 | Cite as

The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients

  • Antoine Gros
  • Mikael Roussel
  • Elise Sauvadet
  • Arnaud Gacouin
  • Sophie Marqué
  • Loïc Chimot
  • Sylvain Lavoué
  • Christophe Camus
  • Thierry Fest
  • Yves Le TulzoEmail author
Original

Abstract

Purpose

CD64 expression on the surface of neutrophils has recently been proposed as an early marker of bacterial infection. The goal of this study was to determine whether the CD64 index allows differentiation of bacterial sepsis from viral and fungal sepsis and other inflammatory states in a critical-care setting.

Methods

This was an observational prospective study conducted in a medical ICU of a university hospital. All patients admitted between September 2009 and March 2010 with at least two criteria for systemic inflammatory response syndrome (SIRS) were eligible for inclusion. Upon admission, hematological exams were conducted by flow cytometry, allowing quantification of CD64 expression (Leuko64™ kit, Trillium Diagnostics LLC, USA). ROC curve analysis was performed to evaluate the utility of the CD64 index in the diagnosis of bacterial infection. Patients with suspected infection were excluded when infection could not be microbiologically confirmed.

Results

Our study included 293 patients with a SAPS II score of 45 (31–59). Bacterial infection was found in 148 patients and SIRS or non-bacterial infection was documented in 145 patients. A CD64 index greater than 2.2 predicted bacterial infection with a sensitivity and specificity of 63% (55–71%) and 89% (83–94%), respectively. The area under the ROC curve was 0.8 (0.75–0.84). Positive and negative likelihood ratios were 5.7 (5.0–6.5) and 0.4 (0.3–0.7), respectively.

Conclusions

The CD64 index is specific for bacterial infection among ICU patients. As a result of its weak sensitivity, the CD64 index may not be practically recommended, but it may be useful in combination with a more sensitive biological marker.

Keywords

Neutrophil CD64 Sepsis Critically ill patients Bacterial infection Diagnostic accuracy SIRS 

Notes

Acknowledgments

The authors thank BH Davis (Trillium Diagnostics, Brewer, ME, USA) for supplying reagents.

Conflicts of interest

None.

References

  1. 1.
    Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310PubMedCrossRefGoogle Scholar
  2. 2.
    Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRefGoogle Scholar
  3. 3.
    Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM (2004) New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 4:751–760PubMedCrossRefGoogle Scholar
  4. 4.
    Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34:1996–2003PubMedCrossRefGoogle Scholar
  5. 5.
    Tang BM, Eslick GD, Craig JC, McLean AS (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7:210–217PubMedCrossRefGoogle Scholar
  6. 6.
    Mongardon N, Lemiale V, Perbet S, Dumas F, Legriel S, Guerin S, Charpentier J, Chiche JD, Mira JP, Cariou A (2010) Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients. Intensive Care Med 36:92–99PubMedCrossRefGoogle Scholar
  7. 7.
    Jiyong J, Tiancha H, Wei C, Huahao S (2009) Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Med 35:587–595PubMedCrossRefGoogle Scholar
  8. 8.
    Davis BH, Olsen SH, Ahmad E, Bigelow NC (2006) Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients. Arch Pathol Lab Med 130:654–661PubMedGoogle Scholar
  9. 9.
    Icardi M, Erickson Y, Kilborn S, Stewart B, Grief B, Scharnweber G (2009) CD64 index provides simple and predictive testing for detection and monitoring of sepsis and bacterial infection in hospital patients. J Clin Microbiol 47:3914–3919PubMedCrossRefGoogle Scholar
  10. 10.
    Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, Kopitar AN, Gmeiner-Stopar T, Derganc M (2009) Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med 35:1950–1958PubMedCrossRefGoogle Scholar
  11. 11.
    Bhandari V, Wang C, Rinder C, Rinder H (2008) Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 121:129–134PubMedCrossRefGoogle Scholar
  12. 12.
    Cardelli P, Ferraironi M, Amodeo R, Tabacco F, De Blasi RA, Nicoletti M, Sessa R, Petrucca A, Costante A, Cipriani P (2008) Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol 21:43–49PubMedGoogle Scholar
  13. 13.
    Hsu KH, Chan MC, Wang JM, Lin LY, Wu CL (2011) Comparison of Fcgamma receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients. Respirology 16:152–160PubMedCrossRefGoogle Scholar
  14. 14.
    Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256PubMedCrossRefGoogle Scholar
  15. 15.
    Groselj-Grenc M, Ihan A, Derganc M (2008) Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm 2008:202646PubMedCrossRefGoogle Scholar
  16. 16.
    Martin C, Garnier F, Vallet B (2005) Recommendations for management of severe sepsis and septic shock. Surviving Sepsis Campaign. Ann Fr Anesth Reanim 24:440–443PubMedCrossRefGoogle Scholar
  17. 17.
    Cohen J, Brun-Buisson C, Torres A, Jorgensen J (2004) Diagnosis of infection in sepsis: an evidence-based review. Crit Care Med 32:S466–S494PubMedCrossRefGoogle Scholar
  18. 18.
    Cid J, Aguinaco R, Sanchez R, Garcia-Pardo G, Llorente A (2010) Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis. J Infect 60:313–319PubMedCrossRefGoogle Scholar
  19. 19.
    Gamez-Diaz LY, Enriquez LE, Matute JD, Velasquez S, Gomez ID, Toro F, Ospina S, Bedoya V, Arango CM, Valencia ML, De La Rosa G, Gomez CI, Garcia A, Patino PJ, Jaimes FA (2011) Diagnostic accuracy of HMGB-1, sTREM-1, and CD64 as markers of sepsis in patients recently admitted to the emergency department. Acad Emerg Med 18:807–815PubMedCrossRefGoogle Scholar
  20. 20.
    Nuutila J (2010) The novel applications of the quantitative analysis of neutrophil cell surface FcgammaRI (CD64) to the diagnosis of infectious and inflammatory diseases. Curr Opin Infect Dis 23:268–274PubMedCrossRefGoogle Scholar
  21. 21.
    Livaditi O, Kotanidou A, Psarra A, Dimopoulou I, Sotiropoulou C, Augustatou K, Papasteriades C, Armaganidis A, Roussos C, Orfanos SE, Douzinas EE (2006) Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. Cytokine 36:283–290PubMedCrossRefGoogle Scholar

Copyright information

© Copyright jointly held by Springer and ESICM 2012

Authors and Affiliations

  • Antoine Gros
    • 1
  • Mikael Roussel
    • 2
  • Elise Sauvadet
    • 1
  • Arnaud Gacouin
    • 1
  • Sophie Marqué
    • 1
  • Loïc Chimot
    • 1
  • Sylvain Lavoué
    • 1
  • Christophe Camus
    • 1
  • Thierry Fest
    • 2
  • Yves Le Tulzo
    • 1
    Email author
  1. 1.Division of Infectious Diseases and Critical CarePontchaillou HospitalRennes CedexFrance
  2. 2.Hematology and Immunology LaboratoryPontchaillou HospitalRennes CedexFrance

Personalised recommendations